{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:15:54Z","timestamp":1788999354030,"version":"build-2803163510"},"reference-count":38,"publisher":"American Society for Clinical Investigation","issue":"15","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"crossref","award":["Sa1960\/5-1"],"award-info":[{"award-number":["Sa1960\/5-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,8,8]]},"abstract":"<jats:p>\n                    The treatment of most autoimmune diseases still relies on systemic immunosuppression and is associated with severe side effects. The development of drugs that more specifically abrogate pathogenic pathways is therefore most desirable. In nature, such specificity is exemplified, e.g., by the soft tick\u2013derived biotherapeutic Coversin, which locally suppresses immune responses by inhibiting complement factor 5 (C5) and leukotriene B\n                    <jats:sub>4<\/jats:sub>\n                    (LTB\n                    <jats:sub>4<\/jats:sub>\n                    ). C5a, a proteolytic fragment of C5, and LTB\n                    <jats:sub>4<\/jats:sub>\n                    are critical drivers of skin inflammation in pemphigoid diseases (PDs), a group of autoimmune blistering skin diseases. Here, we demonstrate that both Coversin and its mutated form L-Coversin, which inhibits LTB\n                    <jats:sub>4<\/jats:sub>\n                    only, dose dependently attenuate disease in a model of bullous pemphigoid\u2013like epidermolysis bullosa acquisita (BP-like EBA). Coversin, however, reduces disease more effectively than L-Coversin, indicating that inhibition of C5 and LTB\n                    <jats:sub>4<\/jats:sub>\n                    synergize in their suppressing effects in this model. Further supporting the therapeutic potential of Coversin in humans, we found that C5a and LTB\n                    <jats:sub>4<\/jats:sub>\n                    are both present in the blister fluid of patients with BP in quantities inducing the recruitment of granulocytes and that the number of cells expressing their receptors, C5aR1 and BLT1, respectively, is increased in perilesional skin. Collectively, our results highlight Coversin and possibly L-Coversin as potential therapeutics for PDs.\n                  <\/jats:p>","DOI":"10.1172\/jci.insight.128239","type":"journal-article","created":{"date-parts":[[2019,8,7]],"date-time":"2019-08-07T11:00:57Z","timestamp":1565175657000},"source":"Crossref","is-referenced-by-count":46,"title":["Dual inhibition of complement factor 5 and leukotriene B4 synergistically suppresses murine pemphigoid disease"],"prefix":"10.1172","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6349-8852","authenticated-orcid":true,"given":"Tanya","family":"Sezin","sequence":"first","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sripriya","family":"Murthy","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Attah","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malte","family":"Seutter","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maike M.","family":"Holtsche","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5631-2415","authenticated-orcid":true,"given":"Christoph M.","family":"Hammers","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enno","family":"Schmidt","sequence":"additional","affiliation":[{"name":"L\u00fcbeck Institute for Experimental Dermatology, and"},{"name":"Center for Research on Inflammation of the Skin, University of L\u00fcbeck, L\u00fcbeck, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fibi","family":"Meshrkey","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2861-8078","authenticated-orcid":true,"given":"Sadegh","family":"Mousavi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Detlef","family":"Zillikens","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"},{"name":"Center for Research on Inflammation of the Skin, University of L\u00fcbeck, L\u00fcbeck, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles A.","family":"Nunn","sequence":"additional","affiliation":[{"name":"Akari Therapeutics, London, United Kingdom."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6701-048X","authenticated-orcid":true,"given":"Christian D.","family":"Sadik","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Allergy, and Venereology,"},{"name":"Center for Research on Inflammation of the Skin, University of L\u00fcbeck, L\u00fcbeck, Germany."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"232","published-online":{"date-parts":[[2019,8,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(12)61140-4"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1111\/bjd.15405"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1111\/1346-8138.14503"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/j.jid.2016.12.021"},{"key":"B5","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00535","article-title":"Specific Inhibition of complement activation significantly ameliorates autoimmune blistering disease in mice","volume":"9","author":"Mihai","year":"2018","journal-title":"Front Immunol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.2862"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1172\/JCI21386"},{"key":"B8","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2018.00488","article-title":"Tissue destruction in bullous pemphigoid can be complement independent and may be mitigated by C5aR2","volume":"9","author":"Karsten","year":"2018","journal-title":"Front Immunol"},{"issue":"7","key":"B9","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1001\/archderm.1989.01670190059006","article-title":"Mediators of inflammation in blister fluids from patients with pemphigus vulgaris and bullous pemphigoid","volume":"125","author":"Grando","year":"1989","journal-title":"Arch Dermatol"},{"issue":"4","key":"B10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2340\/0001555570281285","article-title":"Increased levels of immunoreactive leukotriene B4 in blister fluids of bullous pemphigoid patients and effects of a selective 5-lipoxygenase inhibitor on experimental skin lesions","volume":"70","author":"Kawana","year":"1990","journal-title":"Acta Derm Venereol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1172\/JCI107359"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.174.4.2084"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M609858200"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101000"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M112.420331"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/nsmb.3196"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.bmc.2017.09.016"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1021\/acs.bioconjchem.6b00369"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016002832"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1177\/0961203314546022"},{"key":"B21","doi-asserted-by":"crossref","DOI":"10.1186\/s13054-015-1129-9","article-title":"Combined inhibition of complement and CD14 improved outcome in porcine polymicrobial sepsis","volume":"19","author":"Skjeflo","year":"2015","journal-title":"Crit Care"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1400341"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1201909"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21536"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-017-0610-9"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1016\/j.smim.2018.03.002"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1549"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1609"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1038\/nchembio.118"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0811402"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.it.2011.06.008"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1213797109"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2006.02.006"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/jlb.53.3.301"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2005.06559.x"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1002\/path.1674"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1002\/path.2157"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9440(10)65295-9"}],"container-title":["JCI Insight"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/insight.jci.org\/articles\/view\/128239\/files\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:26:57Z","timestamp":1779193617000},"score":1,"resource":{"primary":{"URL":"https:\/\/insight.jci.org\/articles\/view\/128239"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,8]]},"references-count":38,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2019,8,8]]},"published-print":{"date-parts":[[2019,8,8]]}},"alternative-id":["10.1172\/jci.insight.128239"],"URL":"https:\/\/doi.org\/10.1172\/jci.insight.128239","relation":{},"ISSN":["2379-3708"],"issn-type":[{"value":"2379-3708","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,8]]},"article-number":"e128239"}}